{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Guanfacine Hydrochloride is a generic prescription medication available as oral tablets in 1mg and 2mg strengths. It acts as a central alpha-2 adrenergic agonist, commonly used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents, and sometimes for high blood pressure in adults. Manufactured by Xiromed, LLC, under application ANDA218326. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Guanfacine hydrochloride \u2014 ANDA 074796 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074796", "mediaType": "text/html", "title": "Guanfacine hydrochloride"}], "identifier": "ANDA074796", "issued": "2016-09-16", "keyword": ["drug", "public-health", "drug-manufacturers", "drug-safety", "drug-information"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Guanfacine hydrochloride"}